Skip to main content

Cyclerion Therapeutics, Inc. (CYCN)

NASDAQ: CYCN · IEX Real-Time Price · USD
1.99
0.03 (1.53%)
At close: Dec 8, 2021 4:00 PM
1.95
-0.04 (-2.01%)
After-hours:Dec 8, 2021 6:33 PM EST
Market Cap86.20M
Revenue (ttm)3.54M
Net Income (ttm)-60.10M
Shares Out43.32M
EPS (ttm)-1.63
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume138,959
Open2.00
Previous Close1.96
Day's Range1.90 - 2.04
52-Week Range1.62 - 6.90
Beta1.71
AnalystsStrong Buy
Price Target10.50 (+427.6%)
Earnings DateNov 4, 2021

About CYCN

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its product candidates include CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase II trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and Alzheimer's disease with vascular pathology (ADv); Olinciguat, an orally administered vascular soluble guanylate cy...

IndustryBiotechnology
Employees34
Stock ExchangeNASDAQ
Ticker SymbolCYCN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for CYCN stock is "Strong Buy" and the 12-month stock price forecast is 10.50.

Price Target
$10.50
(427.64% upside)
Analyst Consensus: Strong Buy

News

Cyclerion Therapeutics to Participate in Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive func...

3 weeks ago - GlobeNewsWire

Cyclerion Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update

First patients enrolled in study in Cognitive Impairment Associated with Schizophrenia (CIAS)

4 weeks ago - GlobeNewsWire

Trending Penny Stocks to Buy Now? 5 to Watch This Week

Which trending penny stocks are on your watchlist right now? The post Trending Penny Stocks to Buy Now?

Other symbols:CSCWGOTUINPXKOS
1 month ago - PennyStocks

Truist Bullish On This Clinical-Stage Biopharmaceutical Company With 374% Upside

Truist analyst Joon Lee has initiated coverage of Cyclerion Therapeutics Inc (NASDAQ:CYCN) with a Buy rating and price target of $14, suggesting a massive 374% upside. The development of drugs targeting...

1 month ago - Benzinga

Cyclerion Announces Publication of Preclinical Data Demonstrating Reduction in Neuroinflammation by Brain-Penetrant s...

Company developing lead sGC stimulator, CY6463, in multiple CNS diseases associated with cognitive impairment Company developing lead sGC stimulator, CY6463, in multiple CNS diseases associated with cog...

2 months ago - GlobeNewsWire

Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer's Disease Summit

Presentation to highlight the potential of early clinical assessment of biomarkers to drive development of Alzheimer's disease therapies Presentation to highlight the potential of early clinical assessm...

3 months ago - GlobeNewsWire

Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update

Continuing to progress clinical development of CY6463, a first-in-class, CNS-penetrant soluble guanylate cyclase (sGC) stimulator for the treatment of neurological diseases associated with cognitive imp...

4 months ago - GlobeNewsWire

Cyclerion Therapeutics to Present Clinical Trial Design for CY6463 Phase 2a Study in Participants with Alzheimer's Di...

Research to be presented highlighting potential of neuropsychological biomarkers to guide the clinical development of Cyclerion's investigational therapeutics Research to be presented highlighting poten...

4 months ago - GlobeNewsWire

Cyclerion Recruits Beacon Biosignals To Identify Disease-Relevant EEG Neurological Biomarkers

Cyclerion Therapeutics Inc (NASDAQ: CYCN) and Beacon Biosignals have expanded strategic partnerships between the two companies.  This collaboration is expected to identify disease-relevant biomarkers to...

4 months ago - Benzinga

Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership

BOSTON, July 8, 2021 /PRNewswire/ -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies.  This col...

5 months ago - PRNewsWire

Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership

Beacon Biosignals and Cyclerion to extend and expand partnership on data collection and analytics strategy to facilitate development of Cyclerion investigational therapeutics for neurological diseases a...

5 months ago - GlobeNewsWire

Best Penny Stocks on Reddit to Buy? Check These 4 Out in June

Which penny stocks on Reddit are you watching? Here's 4 for some watchlist inspiration The post Best Penny Stocks on Reddit to Buy?

Other symbols:BOXLPLINVISL
5 months ago - PennyStocks

Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist

Meme penny stocks are heating up; are these 3 on your watchlist? The post Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informati...

Other symbols:AGENMOSY
6 months ago - PennyStocks

Cyclerion Out-Licenses Praliciguat to Akebia, Announces $18M Capital Raise

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has entered into an exclusive, global license agreement with Akebia Therapeutics Inc (NASDAQ: AKBA) for the development and commercialization of praliciguat. Un...

Other symbols:AKBA
6 months ago - Benzinga

Cyclerion Therapeutics Announces $18 Million Private Placement

Proceeds to fund ongoing clinical development of CY6463 and advancement of next generation CY3018 program Proceeds to fund ongoing clinical development of CY6463 and advancement of next generation CY301...

6 months ago - GlobeNewsWire

Cyclerion Therapeutics Announces Global Licensing Agreement with Akebia Therapeutics for Praliciguat

Cyclerion eligible to receive up to $585 million in potential future development and commercial milestone payments, and tiered sales-based royalties

6 months ago - GlobeNewsWire

Cyclerion Therapeutics Announces Publication of CY6463 Preclinical Data in Frontiers in Pharmacology

Series of preclinical studies demonstrate the therapeutic potential of CY6463, a first-in-class, CNS-penetrant sGC stimulator

6 months ago - GlobeNewsWire

Cyclerion Therapeutics to Participate in Jefferies Virtual Healthcare Conference

CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that Company management will present a corporate overview at the Jefferies Virtual Healthca...

6 months ago - GlobeNewsWire

Best Penny Stocks To Buy Right Now? 3 To Know Before Next Week

After this week's market pullback, some of these penny stocks are trending into the weekend. The post Best Penny Stocks To Buy Right Now?

Other symbols:JAGXKXIN
6 months ago - PennyStocks

Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today

Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano Genomics, Inc. (NASDAQ: BNGO) ...

Other symbols:BNGODMTKALDXSLGL
7 months ago - Benzinga

Cyclerion Therapeutics Hosted Webinar to Discuss Pipeline Progress

Provided updates on development strategy and execution for CY6463, a first-in-class, CNS-penetrant sGC stimulator, including IND clearance from FDA in ADv and ongoing MELAS program

7 months ago - GlobeNewsWire

Cyclerion Therapeutics Appoints Errol De Souza, Ph.D., to Board of Directors

Senior CNS expert and biotech business leader to inform strategy and future clinical development Senior CNS expert and biotech business leader to inform strategy and future clinical development

7 months ago - GlobeNewsWire

Best Penny Stocks To Buy Now? 5 For Your Watch List Next Week

5 Penny Stocks To Watch For The Last Week Of April 2021 The post Best Penny Stocks To Buy Now? 5 For Your Watch List Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS...

Other symbols:APTXBLRXLCTXPTN
7 months ago - PennyStocks

Cyclerion Therapeutics to Participate in the B. Riley Neuroscience Investor Conference

CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive fun...

7 months ago - GlobeNewsWire

Cyclerion Therapeutics to Host Pipeline Update Webinar

Company to discuss clinical updates for CY6463, including Phase 2a studies in ADv and MELAS, and plans to initiate Phase 1b clinical trial in CIAS

7 months ago - GlobeNewsWire